JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, J. H.
Right arrow Articles by el-Fakahany, E. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, J. H.
Right arrow Articles by el-Fakahany, E. E.

Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates

JH Lee and EE el-Fakahany

The binding properties of (-)-[3H]quinuclidinyl benzilate and [3H] N- methylscopolamine to muscarinic acetylcholine receptors have been investigated in rat brain homogenates. The binding of both antagonists demonstrated high affinity and saturability. Analysis of the binding data resulted in linear Scatchard plots. However, (-)-[3H]quinuclidinyl benzilate showed a significantly higher maximal binding capacity than that of [3H]N-methylscopolamine. Displacement of both ligands with several muscarinic receptor antagonists resulted in competition curves in accordance with the law of mass-action for quinuclidinyl benzilate, atropine and scopolamine. A similar profile was found for the quaternary ammonium analogs of atropine and scopolamine when [3H]N- methylscopolamine was used to label the receptors. However, when these hydrophilic antagonists were used to displace (-)-[3H] quinuclidinyl benzilate binding, they showed interaction with high- and low-affinity binding sites. On the other hand, the nonclassical muscarinic receptor antagonist, pirenzepine, was able to displace both ligands from two binding sites. The present data are discussed in terms of the relationship of this anomalous heterogenity of binding of these hydrophilic muscarinic receptor antagonists and the proposed M1 and M2 receptor subtypes.

Volume 233, Issue 3, pp. 707-714, 06/01/1985
Copyright © 1985 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
R. A. Bakker, G. Dees, J. J. Carrillo, R. G. Booth, J. F. Lopez-Gimenez, G. Milligan, P. G. Strange, and R. Leurs
Domain Swapping in the Human Histamine H1 Receptor
J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 131 - 138.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. A. Wreggett and J. W. Wells
Cooperativity Manifest in the Binding Properties of Purified Cardiac Muscarinic Receptors
J. Biol. Chem., September 22, 1995; 270(38): 22488 - 22499.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Jakubik, E. E. El-Fakahany, and S. Tucek
Evidence for a Tandem Two-site Model of Ligand Binding to Muscarinic Acetylcholine Receptors
J. Biol. Chem., June 16, 2000; 275(25): 18836 - 18844.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1985 by the American Society for Pharmacology and Experimental Therapeutics.